Prognosis in the era of comparative effectiveness research: Where is nuclear cardiology now and where should it be?
Leslee J. Shaw(American Institute for Economic Research), Ami E. Iskandrian(AstraZeneca (United Kingdom)), Rory Hachamovitch(Allegheny College), Fadi G. Hage(University of Alabama at Birmingham), Daniel S. Berman(Cedars-Sinai Medical Center)
Cited by 128
Related Papers
Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality
|Radiology|2003|895
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes
|JAMA|2009|817
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
|Diabetes Care|2004|789